First human test for new heart pill
Knowledge-focused
Completed
This was a very early safety study for a new drug called THRV-1268, which is being developed for heart failure. Researchers gave single doses to 16 healthy but obese adults to see if it was safe and to measure how the body processes it. The main goal was to check for side effects…
Phase: PHASE1 • Sponsor: Thryv Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC